awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33400232-59C1E218-7C96-41CF-A39B-4858F77E9C5C
Q33400232-59C1E218-7C96-41CF-A39B-4858F77E9C5C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400232-59C1E218-7C96-41CF-A39B-4858F77E9C5C
Dominant effect of antiangiogenesis in combination therapy involving cyclophosphamide and axitinib
P2860
Q33400232-59C1E218-7C96-41CF-A39B-4858F77E9C5C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33400232-59C1E218-7C96-41CF-A39B-4858F77E9C5C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8f3dc94d7c9bb3c232b4ba4bf830a610adc01392
P2860
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study.